trending Market Intelligence /marketintelligence/en/news-insights/trending/5r7kTyo6lJS05S7BEhuLYw2 content esgSubNav
In This List

Simulations Plus closes acquisition of DILIsym Services

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Simulations Plus closes acquisition of DILIsym Services

Simulations Plus Inc. closed the acquisition of North Carolina-based DILIsym Services Inc., a provider of drug-induced liver injury-simulation software and related consulting services.

DILIsym became a unit of Simulations and will continue to operate under the name DILIsym. As a result of the acquisition, the total number of Simulations employees is increasing to 81 from 70.

Simulations will pay DILIsym shareholders a potential total all-cash consideration of $10 million for all of the shares of DILIsym.

The initial payment of $5 million was adjusted to about $4.5 million to reflect a $1 million, 18-month holdback to satisfy any indemnifiable claims that may arise pursuant to the terms of the agreement, and an addition of just over $500,000 for excess cash and working capital left in the business by the shareholders.

A three-year earn-out period will exist after the closing, during which up to an additional $5 million, based on the adjusted pretax income of the DILIsym division, can be earned.

Excel Partners acted as exclusive financial adviser to Simulations in the deal. Procopio Cory Hargreaves & Savitch LLP served as legal counsel to the company.